Lesson 09 — Concentration is the shape, not the risk

A third of a hospital’s materials come from a single supplier. That’s medical procurement, not a defect.

Run a supplier-diversity signal across a hospital’s catalogue and the headline number is sobering: a third or more of materials are single-sourced — only one supplier ever shows up against them in a multi-year window.

The first reading is concentration risk — “this hospital is exposed to supplier failure on N% of its inventory”. That reading is not wrong, exactly. But it is naïve. Single-sourcing in medical procurement is the structural state, not a deviation from it.

Why single-source is the structural state

Three converging reasons:

• Regulatory and clinical exclusivity. Many medical devices are licensed to a specific vendor for a specific application. There is no second supplier because the regulator has only approved one. The hospital cannot multi-source what doesn’t have multi-suppliers.
• Implant compatibility chains. Once a hospital commits to a vendor’s hip system, the trays, instruments, prosthetic heads, cement, and stems all come from the same vendor. Switching one component requires switching the whole system. Single-sourcing is what the surgical workflow demands.
• Specialty drugs and orphan products. Drugs for rare diseases are usually licensed to one pharmaceutical company per market. The hospital’s catalogue reflects the market.

The fraction varies by hospital and by category, but a third single-sourced is normal. Some categories (orthopedic implants, oncology drugs, cardiac devices) approach 80% single-sourced by structure.

What changed in the analysis

The signal output didn’t change. The thesis interpretation did.

1. signal_active_single_source is the inventory, not the alarm. The signal counts single-sourced materials honestly. The Explorer surfaces the list with a “structural single-source” badge for materials in known single-vendor categories.
2. thesis_supplier_concentration_risk separates two populations.
   • Structural single-source: a material in a category (implants, oncology, orphan drug) where single-sourcing is the regulatory or clinical norm. Reported but not alerted.
   • Operational single-source: a material in a category where multi-sourcing is possible but the hospital happens to use one supplier. This is the actionable population.
3. The Wisdom anchored a per-tenant 50cents listing the categories where single-sourcing is structural. Materials in those categories are deflated in the risk score.

What stays interesting

• An operational single-source pattern (multi-sourceable category, single supplier in use) is the genuine concentration risk. A change in that pattern over time — new supplier appears, existing supplier disappears — is what the thesis is meant to surface.
• The transition from operational to structural single-source sometimes happens because the alternative supplier exits the market. That transition is itself a signal worth flagging.
• A “diversified” supplier base with high spelling drift (Lesson 04) may be operationally concentrated under the spelling. Concentration measurement is sensitive to supplier-identity quality.

Why this is in a Lessons journal

Because the thesis would otherwise tell every hospital that its concentration risk is critical, every quarter, forever. The naïve concentration measure is correct and useless. The Wisdom is what separates the population that needs attention from the population that is concentrated by design — and what shifts the headline metric from raw concentration to operational concentration.

Sources

• Wisdom: smebit_single_supplier_concentration.yaml
• Provider: a hospital procurement director with medical-supplies oversight
• Anchor signal: signal_active_single_source
• Anchor thesis: thesis_supplier_concentration_risk
• Date Wisdom captured: 2026-05-08